Viewing data from:

NEOPHAM 6.4%

NDA

AMINO ACIDS | N018792 | HOSPIRA INC

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain4 active DMFs4 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

KYOWA HAKKO BIO CO LTDAMINO ACIDS

DMF 31311978

KYOWA HAKKO BIO CO LTDAMINO ACIDS

DMF 31491978

AJINOMOTO HEALTH AND NUTRITION NORTH AMERICA INCAMINO ACIDS

DMF 45551982

SHANGHAI PLUMINO AMINO ACID CO LTDAMINO ACIDS

DMF 320882017

BOOTS FLINT INC SUB BOOTS CO USA INCInactiveAMINO ACIDS

DMF 281946

KYOWA HAKKO KOGYO CO LTDInactiveAMINO ACIDS

DMF 26311976

SIGMA F AND D DIV LTDInactiveAMINO ACIDS & THEIR SODIUM SALT DERIVATIVES RELATIVE TO HFN-130 INDs

DMF 26611976

NIPPON RIKAGAKUYAKUHIN CO LTDInactiveAMINO ACIDS

DMF 58961985

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 6.4% (6.4GM/100ML)

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Jan 17, 1984

No patent or exclusivity listings for this strength.